Page 4 - Memory Disorders News Today

Once a rising star in Uruguayan field hockey, a Duke neuropsychologist now tackles disparities, aiming to reshape how the nation's largest, fastest-growing minority group receives Alzheimer’s and dementia care.

A new study suggests adopting this activity could be linked with better cognition.

A new study suggests adopting this activity could be linked with better cognition.

A beloved father, brother and grandfather is diagnosed with Alzheimer’s.   As the incurable disease moves him toward inevitable death, the stress on him and his devoted family becomes …

When criminal behavior overlaps with degenerative cognitive disease, the justice system often falters

New research shows Los Angeles County tops the list of U.S. counties with greatest number of people living with Alzheimer's disease.

Eisai Co.’s breakthrough Alzheimer’s drug — the first to show it slows the brain-destroying disease — is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties and

The same day Eisai’s Leqembi received full U.S. approval, Medicare officials said the government health program for the elderly will pay for it. But that doesn’t mean patients will be able to get the $26,500-a-year treatment quickly. Doctors at top medical centers said they’re still trying to coordinate required testing, reimbursement and a real-world monitoring system of patients’ side effects and cognitive status.

BIRMINGHAM, Ala. (WIAT) – A new drug received full FDA approval for early-onset Alzheimer’s treatment. Alzheimer’s for Central Alabama says this is a step in the right direction for treatment and hopes with more research a cure can be found. “We had a drug that was approved last June, the first drug, Aduhelm, had a […]

UAB was involved in clinical trials that led to an accelerated approval of the drug lecanemab, commercially known as Leqembi, in January 2023. A UAB Alzheimer’s expert discusses the therapy and what full approval means f...